dimecres, 12 de febrer del 2014

HeartSine warned by FDA for medtech reporting, tracking violations




The FDA warns HeartSine Technologies for violations related to adverse event reporting standards and medical device tracking at a Pennsylvania AED manufacturing facility.





HeartSine warned by FDA for medtech reporting, tracking violations

HeartSine Technologies is in more hot water with the FDA this month after receiving an agency warning letter citing medical device reporting and tracking violations at a Pennsylvania facility.



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1eUUPJF

Cap comentari:

Publica un comentari a l'entrada